Business

AbbVie shares tumble after schizophrenia drug disappoints – Financial Times

Admin


  1. AbbVie shares tumble after schizophrenia drug disappoints  Financial Times
  2. AbbVie tumbles on drug test disappointment, Bristol-Myers gains  Yahoo Finance
  3. Bristol Soars 11% As Investors Question AbbVie’s Costly ‘Mistake’  Investor’s Business Daily
  4. Crown jewel from AbbVie’s Cerevel buyout fails two Phase 2 schizophrenia tests, Bristol Myers’ stock soars  Endpoints News
  5. What’s Going On With Bristol-Myers Squibb Shares Monday?  Benzinga





Source link

Leave a Reply

Your email address will not be published. Required fields are marked *